Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Dynavax Technologies Corporation
About DVAX
Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company developing and commercializing vaccines to help protect against infectious diseases. The Company has two commercial products: HEPLISAV-B vaccine (Hepatitis B Vaccine (Recombinant), Adjuvanted), and CpG 1018 adjuvant. The HEPLISAV-B vaccine is used for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose in-one-month adult hepatitis B vaccine. CpG 1018 adjuvant is used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. The Company is advancing a pipeline of differentiated product candidates that leverage its CpG 1018 adjuvant to develop improved vaccines in indications with unmet medical needs. Its pipeline programs include Shingles vaccine program (Z-1018) and Plague vaccine program. Z-1018 is an investigational vaccine candidate being developed for the prevention of shingles in adults aged 50 and older.
Find out what a historical investment in Dynavax Technologies Corporation would be worth today using our DVAX stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy DVAX shares in Australia?
Buying DVAX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Dynavax Technologies Corporation in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in DVAX
What is the ticker symbol of Dynavax Technologies Corporation?
The ticker symbol for Dynavax Technologies Corporation is DVAX.
How much is one share of DVAX?
One share of DVAX is valued at $15.50 as of 21 May 2026.
What is the market capitalisation of Dynavax Technologies Corporation DVAX?
As of 21 May 2026 Dynavax Technologies Corporation has a market cap of -.
What is the 52-week high for Dynavax Technologies Corporation stock?
The Dynavax Technologies Corporation 52-week high stock price is $NaN.
What is the 52-week low for Dynavax Technologies Corporation stock?
The Dynavax Technologies Corporation 52-week low stock price is $NaN.
Can I buy DVAX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy DVAX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in DVAX on Stake
- Buy DVAX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of DVAX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
DVAX related stocks